Abiomed Inc’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Abiomed provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart failure patients.  Read more

803 Followers on Owler
803 Followers on Owler
803 Followers on Owler
803 Followers on Owler

Abiomed provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart failure patients.  Read more

Michael R. Minogue's photo - Chairman & CEO of Abiomed Inc

Chairman & CEO

Michael R. Minogue

CEO Approval Rating

100/100

Founded:

1981

Status:

PublicIndependent CompanyNASDAQABMD

Annual Revenue
Employees
Sector

- -

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

HeartWare, Inc. is seen as one of Abiomed Inc's biggest rivals. HeartWare, Inc. was founded in 1995 in Framingham, Massachusetts. HeartWare, Inc. operates in the Health Care Equipment industry. HeartWare, Inc. generates $540.4M less revenue than Abiomed Inc.

Thoratec is one of Abiomed Inc's top competitors. Thoratec was founded in 1976, and its headquarters is in Pleasanton, California. Thoratec operates in the Health Care Supplies industry. Thoratec has 323 fewer employees than Abiomed Inc.

Conformis is one of Abiomed Inc's top rivals. Conformis was founded in 2004, and is headquartered in Billerica, Massachusetts. Conformis is in the Health Care Equipment field. Conformis generates $730.9M less revenue vs. Abiomed Inc.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is OrganOx a competitor of Abiomed Inc?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$802.9M

Abiomed Inc's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 5.1B. Over the last four quarters, Abiomed Inc's revenue has decreased by 5.3%. Specifically, in Q3 2020's revenue was $209.8M; in Q2 2020, it was $164.8M; in Q1 2020, it was $206.7M; in Q4 2019, Abiomed Inc's revenue was $221.6M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Breethe, Inc.

Apr 2020

Source »
undisclosed
Breethe is a medical device company that develops and commercializes ECMO systems for treating patients with acute and chronic lung failure.

-

-

Jun 2014

Source »
$30M
-

These are all the companies that Abiomed Inc has acquired. Abiomed Inc has acquired 2 companies and its latest acquisition was Breethe, Inc. in Apr 2020. Breethe is a medical device company that develops and commercializes ECMO systems for treating patients with acute and chronic lung failure.

Abiomed Inc Funding History

$42.1M

Since Abiomed Inc was founded in 1981, it has participated in 1 round of funding. In total Abiomed Inc has raised $42.1M. Abiomed Inc's funding round was on Aug 2008 for a total of $42.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Aug 2008
$42.1M

Since Abiomed Inc was founded in 1981, it has participated in 1 round of funding. In total Abiomed Inc has raised $42.1M. Abiomed Inc's funding round was on Aug 2008 for a total of $42.1M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Impulse Dynamics is a medical device company that develops cardiac contractility modulation therapy for the treatment of chronic heart failure.
$80.3M
Dec 02, 2019
Series D
-
Protembis designs and develops cerebral protection systems for transcatheter aortic valve replacement surgery procedures.
$10M
Oct 25, 2018
Series A
-
RenalGuard develops Contrast-Induced Nephropathy for the cardiovascular treatment.
$7M
Sep 13, 2018
Equity
-
Reprieve Cardiovascular designs and manufactures medical devices for the treatment of patients suffering from acute decompensated heart failure.
$7M
Sep 11, 2018
Equity
-
Magenta Medical is a manufacturer of balloon catheter device for the treatment of acute and chronic heart failure.
$15M
Sep 28, 2017
Unattributed
-

These are all the companies that Abiomed Inc has invested in. Abiomed Inc has invested 2 companies and its latest investment was Breethe, Inc. in Apr 2020. Breethe is a medical device company that develops and commercializes ECMO systems for treating patients with acute and chronic lung failure.

Abiomed Inc News

October 29, 2020FinanzNachrichten

First Patients Treated with the World's Smallest Heart Pump, the 9Fr Impella ECP

Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expand... See more »
October 28, 2020Pharmabiz

US FDA grants 510(k) clearance to Abiomed's compact cardiopulmonary bypass support technology, Breethe OXY1 system

Abiomed announced that the United States Food and Drug Administration (FDA) have granted a 510(k) cle... See more »
October 28, 2020FierceBiotech

FDA clears Abiomed's Breethe lung life support system, enabling use in COVID-19

FDA clears Abiomed's Breethe lung life support system, enabling use in COVID-19 chale Wed, 10/28/2020... See more »
October 15, 2020MarketScreener

Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes

(marketscreener.com) Abiomed announces new PROTECT III study data that demonstrates reduced rates of ... See more »
October 15, 2020Medical Design and Outsourcing

Abiomed touts latest Impella trial results

Abiomed (NSDQ:ABMD) today announced interim results of a study that found high-risk patients had bett... See more »

Abiomed Inc Press Releases

September 14, 2020Business Wire

Abiomed to Hold Fireside Chat at the Raymond James North American Equities Conference

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed to hold fireside chat at the Raymond James North American Eq... See more »
May 20, 2020Business Wire

Abiomed to Host Virtual Clinical Data and Innovation Day

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed to host virtual clinical data and innovation day.... See more »
March 4, 2020StreetInsider

Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Death and Complications in Patients who Receive PVADs (Impella)

DANVERS, Mass.--(BUSINESS WIRE)-- A study of 21,848 non-emergent, high-risk patients who underwent pe... See more »
September 28, 2019Newsfile

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Abiomed, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - September 27, 2019) - Faruqi & Faruqi, LLP, a leading national ... See more »
September 23, 2019Business Wire

Highest Court in Germany Affirms Strength of Abiomed's Patents

DANVERS, Mass.--(BUSINESS WIRE)-- #HeartRecovery--The highest court in Germany recently ruled in favo... See more »
September 12, 2019GlobalNewswire

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Abiomed, Inc. To Contact The Firm

NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law ... See more »
August 31, 2019GlobalNewswire

ROSEN, A HIGHLY RANKED LAW FIRM, Reminds Abiomed, Inc. Investors of Important Deadline in Securities Class Action - ABMD

NEW YORK, Aug. 31, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, remind... See more »

Abiomed Inc Videos

Social Media

Headquarters

22 Cherry Hill Dr

Danvers, Massachusetts01923

978-646-1400

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Abiomed provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart failure patients.  Abiomed Inc was founded in 1981. Abiomed Inc's headquarters is located in Danvers, Massachusetts, USA 01923. It h...

CEO

Abiomed Inc's Chairman & CEO, Michael R. Minogue, currently has an approval rating of 100%. Abiomed Inc's primary competitors are HeartWare, Inc., Thoratec & Conformis.

Website

abiomed.com

Frequently Asked Questions about Abiomed Inc

  1. When was Abiomed Inc founded?

    Abiomed Inc was founded in 1981
  2. Who is Abiomed Inc's CEO?

    Abiomed Inc's CEO is Michael R. Minogue
  3. How much revenue does Abiomed Inc generate?

    Abiomed Inc generates $802.9M in revenue
  4. How much funding does Abiomed Inc have?

    Abiomed Inc has historically raised $42.1M in funding
  1. Where is Abiomed Inc's headquarters?

    Abiomed Inc's headquarters is in Danvers Massachusetts, USA
  2. How many employees does Abiomed Inc have?

    Abiomed Inc has 1,371 employees
  3. Who are Abiomed Inc's competitors?

    Abiomed Inc's top competitors are HeartWare, Inc., Thoratec , Conformis
  4. Who has Abiomed Inc invested in?

    Abiomed Inc's has invested in companies such as Impulse Dynamics, Protembis, RenalGuard